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Abstract.  We report the development of a new 
method for producing mitotic extracts from tissue cul- 
ture cells. These extracts reproducibly promote the 
condensation of chromatin in vitro when incubated 
with purified interphase nuclei. This condensation 
reaction is not species specific, since nuclei from 
chicken, human, and hamster cell lines all undergo 
chromatin condensation upon incubation with the ex- 
tract.  We have used this extract to investigate the role 
of DNA topoisomerase II (topo II) in the chromosome 
condensation process.  Chromatin condensation does 
not require the presence of soluble topo II in the mi- 
totic extract. However, the extent of formation of dis- 
crete chromosome-like structures correlates with the 
level of endogenous topo II present in the interphase 
nuclei. Our results further suggest that chromatin con- 
densation in this extract may involve two processes: 
chromatin compaction and resolution into discrete 
chromosomes. 
T 
HE higher order structure of chromatin changes dra- 
matically during the growth and division cycle of a 
eukaryotic cell. As the cell proceeds into mitosis, the 
interphase chromatin condenses until the metaphase chro- 
mosomes visible by light microscopy are formed. The sue- 
cessful condensation of the chromatin is essential to ensure 
the accurate partitioning of  the genome between the daughter 
cells upon completion of mitosis. 
Chromosome condensation involves successive orders of 
folding of the DNA molecule. Although the exact nature of 
this folding remains the subject of some controversy,  a vari- 
ety of evidence suggests that chromatin is organized into 
loop domains of 50-100 kb in both interphase nuclei and mi- 
totic chromosomes (reviewed in reference 12). Because the 
distribution of histones throughout the chromosome is rela- 
tively even, it has been proposed that the loop domains are 
anchored at their bases by nonhistone proteins. The chromo- 
some scaffold fraction, which consists of a subset of chro- 
mosomal proteins that are resistant to solubilization after 
histone extraction and DNAse treatment, contains proteins 
that may be involved in anchoring these chromatin loops (1, 
6, 24). If the suggestions that scaffold proteins serve a struc- 
tural role in anchoring chromatin loop domains prove to be 
correct, then it seems likely that proteins present in this frac- 
tion may be involved in chromosome condensation. 
The most abundant chromosome scaffold protein is DNA 
topoisomerase H (topo H) 1 (9,  11). Light and electron mi- 
croscopy studies of  the distribution of  topo II in mitotic chro- 
1. Abbreviation used in this paper: topo II, topoisomerase  II. 
mosomes suggest that the enzyme is located at the base of 
the radial loop domains in native chromosomes (7) and in 
nuclei (2).  This localization pattern is consistent with the 
known role of  topo II in chromosome disjunction at anaphase 
(4, 21, 40). 
It has also been proposed that topo II is involved in chro- 
mosome condensation. When Schizosaccharomyces pombe 
is arrested in mitosis through the use of either tubulin mu- 
tants or antitubulin drugs, the cells exhibit three highly con- 
densed chromosomes (41).  Examination of cold-sensitive 
(cs) topo H/cs B-tubulin double mutants ofS. pombe arrested 
in mitosis at nonpermissive temperature reveals the presence 
of much elongated prophase-like chromosomes (39).  This 
has been interpreted as evidence for a role of topo II in the 
final  stages  of condensation.  However,  since  condensed 
chromosomes are not normally formed in S. pombe, it re- 
mains possible that this result is peculiar to this combination 
of mutations and drug treatments. 
A requirement for topo H in chromosome condensation 
has also been suggested by in vitro experiments using ex- 
tracts from Xenopus eggs. Condensation in these extracts was 
blocked by the topoisomerase II inhibitors novobiocin and 
VM26 (30). However, it was unclear if the block in chromo- 
some condensation was due to a specific inhibition of topo 
II or a nonspecific effect of protein-linked DNA gaps result- 
ing from inhibitor treatment. 
We have developed a new in vitro assay for chromatin con- 
densation based upon extracts from mitotic tissue culture 
cells to investigate the role of chromosome scaffold proteins 
in the condensation process.  Similar previously described 
mitotic extracts derived from tissue culture ceils have proven 
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and lamina solubilization, but failed to yield discrete con- 
densed regions of chromatin as occurs during chromosome 
formation in vivo (20,  29,  35). 
The first scaffold protein we have investigated using this 
system is DNA topoisomerase II. Our experimental strategy 
to analyze the role of topo II in condensation relies upon the 
use of cells of a single developmental lineage as a source of 
nuclei containing variable levels of topo II. In the erythroid 
lineage of the embryonic chick, the mitotic index in the pe- 
ripheral blood falls effectively to zero between 6 and 10 d 
of development as erythropoiesis becomes localized to spe- 
cific hematopoietic compartments (31). Earlier studies from 
this laboratory revealed that levels of topo II observed in pe- 
ripheral blood cells drop precipitously over this time period 
as the dividing blast cells are replaced by quiescent primary 
erythrocytes (16). The loss of  topo II from these cells is prob- 
ably a consequence of normal cell cycle processes, in which 
the protein accumulates to peak levels during mitosis and is 
then rapidly degraded during the transition to subsequent G1 
(17). Although it is possible that other chromosomal proteins 
decrease in parallel with topo II over this period of develop- 
ment, we have been unable to detect such a dramatic de- 
crease for any of the other chromosome scaffold proteins for 
which we have specific antibodies. 
In the work reported here, we present the basic character- 
ization of our novel somatic mitotic extract system, together 
with an assessment of the role of endogenous nuclear topo 
II levels  in chromatin condensation. Using nuclei purified 
from developing chick erythroblasts as  substrates  of the 
reaction, we have shown that the extent of the formation of 
discrete  chromosome-like  structures  correlates  with  the 
level of endogenous topo II present in the added nuclei. In- 
terestingly,  overall  compaction of the  nuclear  chromatin 
does not appear to require topo II. The volume of nuclei con- 
taining low levels of topo II decreases by a factor of 2.7 after 
incubation with extract, but there is no sign of resolution into 
discretely  condensed  regions.  These  results  suggest  that 
chromatin condensation in this in vitro system may involve 
two processes: topo II-independent compaction of the chro- 
matin, and resolution of the condensed chromatin into dis- 
crete regions. The latter process may require the presence of 
endogenous nuclear topo II. 
Materials and Methods 
Cell Culture and Synchrony 
Chicken DU249 (hepatoma cells; 22), CHO, and HeLa cells were grown 
in RPMI 1640 (Gibeo Laboratories, Grand Island, NY) plus 5% FBS (Hy- 
Clone Laboratories, Logan, UT). MSB-1  cells, the gift of H. Weintraub 
(Hutchinson Cancer Center, Seattle, WA), were grown in RPMI-1640 sup- 
plemented with 5% newborn calf serum (HyClone Laboratories). For cell 
cycle synchronization, DU249 cells were grown in monolayer culture in 
150-cm  2 tissue culture dishes (Coming Instruments, Coming, NY). When 
the cultures were ,~80% confluent, aphidicolin (Sigma Chemical Co., St. 
Louis, MO) was added to a final concentration of 2 #g/ml. After 12 h of 
incubation, cells were released into fresh culture medium. Cell culture was 
continued for 7 h, at which point nocadozole (Sigma Chemical Co.) was 
added to a final concentration of 50 ng/ml. After 3 h, ,-075% of the cells 
were arrested in metaphase, and we/'e recovered by mechanical shakeoff 
(37). Using this procedure, 90-95 % of the cells obtained were in mitosis, 
as indicated by the lack of a nuclear membrane and the presence of con- 
densed mitotic chromosomes. 
Chicken erythrocytes from various stages of embryonic development 
were obtained from chicken embryos (Truslow Farms, Chestertown, MD) 
as previously described (16). 
Preparation of  Mitotic Extracts 
For a  typical extract production,  10-15  150-cm 2 flasks  of DU249  cells 
were synchronized; the cells were collected as described above. All steps 
subsequent to cell harvest were performed on ice. Mitotic cells were washed 
in 20 vol of ice-cold incomplete lysis buffer (50 mM Pipes-KOH, pH 7.0, 
50 mM KCI, 10 mM EGTA, 2 mM MgCI2, adapted from reference 35), fol- 
lowed by  a  subsequent wash in  20  vol  of complete lysis buffer (lysis 
buffer plus 1 mM DTT,  2 #M cytochalasin B [Sigma Chemical Co.], 0.1 
mM PMSE 1 #g/ml CLAP [chymostatin, leupeptin, antipain, and pepstatin 
A]). The cells were then resuspended in 1 vol of complete lysis buffer, and 
pelleted (325  g, 2 rain) directly into twe to four 0.5-ml glass microtissue 
homogenizers (Wheaton Instruments Div., Milville, NJ). The supernatant 
was removed, and the pelleted ceils were quick frozen in a  -80°C 80% 
isopropanol slush. The frozen cells were lysed by grinding as the pellet 
thawed. This freeze-thaw lysis procedure was repeated twice. A crude cyto- 
plasmic fraction was obtained from the lysed cells by low-speed centrifoga- 
tion (2%000 g for 15 min). The supernatant was collected and clarified by 
high-speed centrifugation (150000 g for 3 h). This soluble mitotic extract 
(supernatant) was then divided into 80-#1 aliquots and stored under liquid 
nitrogen where it remained active for at least 2 mo. Using this procedure, 
the mitotic extract typically has a protein concentration of 50-60 mg/mi. 
Interphase extracts were prepared from logarithmically growing DU249 
cells harvested with a rubber policeman. All subsequent steps were identi- 
cal to those described above. 
Purification of  lnterphase Nuclei 
For isolation of interphase nuclei,  10 #M  cytochalasin B  was added to 
logarithmically growing MSB-1 cells and incubation was continued for 30 
min. The cells were then harvested by centrifugation and washed in 20 vol 
of PBS (Dulbecco's formulation plus 1 mM MgCI2).  A second wash was 
performed in 20 vol of NB (10 mM Hepes-KOH, pH 7.5,  10 mM KCI, 1.5 
mM MgCI2,  1 mM DTT,  10 #M cytochalasin B, 0.1 mM PMSE  1 #g/ml 
CLAP). The washed cells were resuspended in 2 vol of NB and allowed to 
swell for 20 rain on ice. After swelling, the cells were gently lysed by 20 
strokes in a  15-mi Dounce homogenizer. Up to 2 ml of homogenate were 
layered over 4.5 mi of NB plus 30% sucrose in a 40-ml round-bottom cen- 
trifuge tube, and the nuclei were pelleted by centrifugation at 500 g for 3 
min. The nuclei were then washed in  1 ml of complete lysis buffer and 
resuspended at a final concentration of 2  ×  10S/ml. 
Nuclei from developing chick erythroblasts were isolated as described 
above except cell lysis was accomplished with more vigorous and more 
numerous (50-100) strokes of the Dounce homogenizer. 
In Vitro Chromatin Condensation Reactions 
Typical in vitro chromatin condensation reactions (20 ~1) contained, 15 #1 
of mitotic extract (1  x  107 cell equivalents), 3 ~1 of purified nuclei (1.5  × 
106), and an ATP-regenerating system consisting of 2 mM ATP,  10 mM 
creatine phosphate, and 50/zg/ml creatine kinase. Incubations were per- 
formed in a 0.5-ml microfuge tube at 37°C for 90 rain. For buffer controls, 
the mitotic extract was replaced with 15 p.l of lysis buffer. 
To observe chromatin condensation, 10-#1 aliquots were withdrawn and 
fixed by adding 2 vol of  4% formaldehyde in PBS for 5 rain. The fixed nuclei 
were then gently centrifuged onto coverslips, stained with the DNA-specific 
dye,  diaminophenylindole (DAPI),  and  visualized  by  fluorescence mi- 
croscopy. 
Determination of nuclear volume before and after incubation with the mi- 
totic extract was performed using a Hypervision digital image-processing 
system (Perceptics, Knoxville TN). Briefly, the system defined the borders 
of objects in an image above a defined threshold of light intensity. The com- 
puter then calculated the area in pixels for each of the identified objects. 
Volumes for the nuclei were calculated using the value of the radius of each 
nucleus and assuming that the nuclei were spheres. For noncondensed 
nuclei and nuclei incapable of forming discrete condensed regions (late- 
stage erythrocyte nuclei) the volume represents the region occupied by the 
DAPI-stained  chromatin.  For  nuclei  condensed  into  chromosome-like 
structures the volume represents the entire region encompassed by the con- 
densed material (i.e., the condensed chromosome-like structures and the 
area in between them). 
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For lamin immunofluorescence experiments, condensation reactions were 
performed as described above, only the reactions were carded out using 
nuclei that were preattached to adhesioslides (MM Developments, Ottawa, 
Canada).  After a  standard incubation with buffer or mitotic extract, the 
nuclei were fixed and processed for indirect immunofluorescence as de- 
scribed previously (10). The anti-chicken lamin B2 antibody (23) was the 
generous gift of Dr. Erich Nigg (ISREC, Lausanne, Switzerland). 
Quantitation  of the intensity of lamin  immnnofluorescence was per- 
formed using the Hypervision system. Images of nuclei treated with buffer 
or extract and stained with antilamin antibodies were acquired at identical 
gain and contrast settings of the SIT camera (DAGE-MTI Corp., Michigan 
City, IN). Nuclei were then randomly selected and the average intensity of 
fluorescence within each nucleus was automatically determined. Fluores- 
cence intensity was expressed as a value between 0 and 1, with 1 being the 
highest intensity and 0 being completely black. At least 20 individual nuclei 
were averaged to generate each mean value of fluorescence intensity. 
Quantitation of  -Topo H Levels 
Previous work from this laboratory has determined that rapidly growing 
MSB-1 cells contain 4.9  x  105 copies of topo II per cell (15),  thus topo 
II levels were estimated for mitotic extracts and chick erythroblast nuclei 
by comparative immunoblotting using rapidly growing MSB-1  fells as a 
standard. A range of MSB-1 cells (5 x  104-105) were lysed in SDS-sample 
buffer and loaded onto a 10% polyacrylamide gel. Variable amounts of mi- 
totic extract or chicken erythroblast nuclei were processed in a similar fash- 
ion and loaded onto the same gel. An immnnoblot of this gel was subse- 
quently performed as described previously (8), and probed with a specific 
rabbit anti-topo II antibody (19).  Antibody-antigen complexes were de- 
tected using iodinated protein A and visualized by autoradiography. After 
autoradiography the immunoblot was stained with India ink and appropriate 
regions of the nitrocellulose filter were cut out and counted in a gamma 
counter. A standard curve of counts per minute vs. topo II copy number 
was therefore generated using the MSB-1 cells, and the levels of topo II in 
the mitotic extract and in the purified chick erythroblast nuclei were esti- 
mated using this standard curve. 
Immunodepletions 
lmmunodepletions of topo II  from the mitotic extracts were performed 
using topo R-specific guinea pig antibody 2B2 (9).  Fixed Staphylococcus 
aureus cells (Pansorben; Pharmacia Fine Chemicals, Piseataway, NJ) were 
washed three times in 10 vol of PBS plus 4% BSA and resuspended in 1 
volume of this solution. 20 #1 of  guinea pig 2B2 serum or preimmune serum 
were then incubated with 20 #1 of washed Pansorben while rotating on a 
mechanical shaker at 4"C for 1 h. The antibody-preadsorbed  Pansorben was 
then washed as described above. After the final wash, the Pansorben pellet 
was resuspended with 20 #1 of mitotic extract. The extract and Pansorben 
were incubated on ice with intermittent mixing for 1 h. The Pansorben was 
then separated from the extract by centrifugation, and 15 #1 of treated ex- 
tract were removed and used in a chromatin condensation reaction. 2 #1 of 
remaining extract were then analyzed for topo II levels by immunoblotting. 
The Pansorben pellets were washed three times with 50 vol of KB per wash 
(150 mM NaCI,  10 mM Tris-HCl [pH 7.7], 0.1% Triton X-100, 0.1% BSA), 
resuspended in 40 #1 of SDS-sample buffer, boiled for 5 rain, centrifuged 
briefly to pellet the Pansorben, and loaded onto the same polyacrylamide 
gel as the extract supernatants. 
Results 
Mitotic Extracts from Somatic Cells Promote 
Chromatin Condensation In Vitro when Incubated 
with Purified Interphase Nuclei 
Highly concentrated (50-60  mg/ml protein)  extracts pre- 
pared from mitotic cells of the chicken hepatoma-derived 
line DU249 induce chromatin condensation in added inter- 
phase nuclei (Fig. 1, c and d). In a typical in vitro chromatin 
condensation reaction, the extract is incubated with purified 
interphase nuclei from the chicken lymphoblastoid cell line, 
MSB-1  in the presence of an ATP-regenerating system at 
37°C for 90 rain. Under these conditions, the chromatin in 
the extract-treated nuclei is condensed into numerous dis- 
crete structures (Fig. 1, c and d). The observed condensation 
is not due to any components of the lysis buffer, since cells 
treated with buffer alone do not exhibit any change in the 
condensation state (Fig.  1, a  and b). 
Condensation of  the interphase chromatin is first observed 
after 20 min incubation with the extract and is complete after 
60-90 rain. The condensation reaction is also relatively sen- 
sitive to dilution of  the mitotic extract. Dilution of  the extract 
by a factor of 3 abolishes chromatin condensation (data not 
shown). 
A  cytological spread  of DAPI-stained mitotic chromo- 
somes  from  DU249  cells  (diploid  chromosome  number 
~60) is shown in Fig. 2 a. A comparison of DU249 nuclei 
(Fig. 2 b) or MSB nuclei (Fig. 2 c) condensed in vitro reveals 
that the products of the condensation reaction are roughly 
similar to naturally occurring chromosomes in both size and 
number. 
Chromatin-condensing Activity Is Enhanced 
in Mitotic Extracts 
We have prepared identical extracts from mitotic cells (M ex- 
tracts), logarithmically growing cells (log extracts), or cells 
blocked at the G1/S boundary by aphidicolin treatment (S ex- 
tracts) to investigate the effect of the cell cycle phase from 
which the extract is made upon chromatin condensation in 
vitro. As expected chromatin condensation of added nuclei 
occurs with high frequency in M  extracts (Fig.  3 b).  The 
proportion of nuclei condensed using these extracts ranged 
from 82-98 % (50 different  M extracts have been prepared). 
In some of our interphase extracts (four different log extracts 
and two S extracts have been tested) we observed low and 
variable levels of  apparent chromatin condensation (Fig. 3 a, 
nucleus on top right is slightly condensed). However,  dilu- 
tion of  the extracts reveals that the chromatin-condensing ac- 
tivity is consistently much higher in mitotic extracts than in 
interphase extracts. 
Basic Characteristics of the In Vitro Chromatin 
Condensation Reaction 
Chromatin condensation using this somatic system is sensi- 
tive to increased concentrations of divalent cations.  More 
than 2 mM Ca  2+ and >10 mM Mg  2+ added to the reaction 
result in essentially complete inhibition of chromatin con- 
densation. The reaction is also sensitive to Tris buffers (>4 
mM inhibits condensation) and DMSO (>3 % inhibits con- 
densation). Heat treatment of the extract at 65°C for 10 min 
also abolishes chromatin condensation. Together,  these ob- 
servations suggest that the condensation observed is not due 
to nonspecific aggregation of the chromatin. 
Mitotic Extracts Promote Chromatin Condensation 
in Nuclei from a Variety of  Sources 
In addition to nuclei from chicken MSB-1 cells, nuclei from 
untransformed chicken fibroblasts (not shown), HeLa (Fig. 
4 a), CHO (Fig. 4 b) and even Drosophila tissue culture cells 
(not shown) undergo chromatin condensation when incu- 
bated with the extracts. The proportion of these nuclei that 
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sation  in vitro  using  mitotic 
extracts  from somatic  cells. 
Purified MSB-1 nuclei were 
treated  with  lysis  buffer  (a 
and b)  or mitotic  extract  (c 
and  d),  fixed with  3%  for- 
maldehyde in PBS, and gently 
centrifuged  onto  coverslips. 
(a and c) DAPI  staining.  (b 
and d)  Phase  contrast.  Bar, 
10/~M. 
condenses upon  incubation with the extract is  essentially 
identical to the proportion of MSB-1  nuclei that condense 
(>90%). The number of condensed chromosome-like struc- 
tures seen when nuclei from these various cell types are used 
as substrates of the condensation reaction roughly correlates 
with the chromosome number for each cell type. 
The Somatic Mitotic Extract Catalyzes the 
Solubilization  of the Nuclear Lamina 
We have investigated nuclear lamina solubilization during 
the in vitro chromatin condensation reaction by immuno- 
fluorescence with an antibody to chicken lamin B2. Purified 
MSB-1 nuclei treated with buffer alone are stained preferen- 
tially around the nuclear periphery by the lamin B2 antibody 
in a fashion similar to that previously reported for the nu- 
clear lamina (Fig. 5 b) (13), and the chromatin remains un- 
condensed (Fig. 5 a). The intensity of lamina staining with 
the lamin B2 antibody is greatly reduced upon incubation of 
purified MSB-1 nuclei with the mitotic extract (Fig. 5 d) and 
chromatin condensation occurs as usual (Fig. 5 c). The re- 
duction in lamin B2 staining intensity is presumably due to 
the solubilization of the nuclear lamina. 
The degree of lamina solubilization has been estimated by 
quantitation of the lamin B2 immunofluorescence intensi- 
fies. The average intensity of lamin B2 immunofluorescence 
in the buffer treated nuclei was 0.72, (arbitrary units, aver- 
aged for 20 randomly picked nuclei) whereas the average in- 
tensity of lamin immunofluorescence in the extract treated 
nuclei  was  0.09.  Thus,  lamin  B2  immunofluorescent in- 
tensity is reduced by •87%  upon treatment with mitotic 
extract. 
Chromatin Condensation In Vitro Using MSB-1 
Nuclei Is Not Dependent upon Soluble Topoisomerase 
H in the Mitotic Extract 
Our motivation for developing the in vitro chromatin con- 
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condensation  reaction  compared  to  naturally 
formed  mitotic  chromosomes.  (,4)  Cytological 
spread of mitotic chicken DU249 cell stained with 
DAPI.  (B  and  C)  Nuclei  purified  from  either 
chicken DU249 (B) or MSB-1 (C) cells were treat- 
ed with mitotic extract and processed as described 
for Fig.  1.  Bar,  10 #M. 
Figure 3. Chromatin condensation in 
vitro using extracts from logarithmi- 
cally growing or mitotic cells. Iden- 
tical  extracts  were  prepared  from 
logarithmically growing  or  mitotic 
DU249 cells and incubated with pu- 
rified MSB-1 nuclei. (A) MSB-I nu- 
clei  treated  with  log  extract.  (B) 
MSB-1  nuclei  treated  with  mitotic 
extract. Bar,  10 #M. Figure 4. Incubation of human and hamster cells with mitotic extract. Nuclei purified from (A) HeLa:and (B) CHO ceils were incubated 
with mitotic extract, stained with DAPI, and processed as described for Fig.  1. Bar, 10/~M. 
densation system was to provide a means to investigate the 
role of individual chromosome scaffold proteins in the chro- 
mosome condensation process. Somatic cell extracts may be 
ideal for such a study since they do not contain large stock- 
piles of nonhistone chromosomal proteins as do extracts de- 
rived from amphibian eggs. The first scaffold protein we have 
examined using this system is DNA topoisomerase II. 
Our strategy for testing the hypothesis that topo II is re- 
quired  for  chromosome  condensation  has  been  to  ask 
whether condensation can occur in the absence of the pro- 
tein. This strategy is complicated by the fact that topo 1I is 
provided by two sources in a typical in vitro condensation ex- 
periment. The enzyme is present in a soluble form in the mi- 
totic extract, and also is tightly coupled to the ehromatin in 
the purified MSB-1  nuclei. 
The level of topo II in actively growing chicken DU249 
cells (from which the extract is made) has been determined 
by quantitative immunoprecipitation to be 4.9 x  1@ mono- 
mers per nucleus (15).  Therefore, the level of topo II in the 
mitotic extract can be accurately determined by comparative 
immunoblotting using DU249 cells as a standard.  We have 
used this  quantitative immunoblotting approach  to deter- 
mine that our mitotic extracts retain only 2 % of the total 
topo II originally present in the DU249 cells. This very low 
recovery of soluble topo II is not surprising since the chro- 
mosomes of the mitotic DU249 cells are removed from the 
soluble extract by sedimentation during extract preparation, 
and it has been previously shown that topo II is tightly as- 
sociated with mitotic chromosomes (9,  11). 
Even though the level of topo II in the mitotic extract is 
low, it is possible that the soluble topo II is enough to fulfill 
any requirement for the enzyme in the condensation reac- 
tion. We have tested the requirement for soluble topo II by 
immtmodepletion of the enzyme from the mitotic extract 
using an anti-topo II antibody (9). Antibody treatment quan- 
titatively removes soluble topo II from the extract (Fig. 6). 
The level of topo II in the untreated extract is shown in Fig. 
6, lane 1. Topo H-specific polyclonal antibodies completely 
immunoprecipitate all detectable topo II from the mitotic ex- 
tract (Fig. 6, lane 4). The precipitated topo II is recovered 
in the pellet fraction (Fig. 6, lane 8). The levels of topo II 
are not significantly affected by treatment with preimmune 
serum, or formaldehyde fixed S.  aureus cells alone (Fig. 6, 
lanes 2 and 3). 
When the topo II-immunodepleted mitotic extract is in- 
cubated with MSB-1 nuclei, chromatin condensation occurs 
in a  fashion indistinguishable from the condensation cata- 
lyzed by the untreated extract (compare Fig. 7, b and c). Ex- 
tracts mock-depleted with either preimmune serum or im- 
munoadsorbant alone also retain full activity (not shown). 
This indicates that if topo II is required for chromatin con- 
densation,  then endogenous enzyme present in the nuclei 
themselves is enough to fulfill this requirement. 
Previous results  have  shown  that  topo II  is  tightly as- 
sociated with the nuclear matrix in interphase nuclei (2). It 
is therefore not practical to remove the enzyme from nuclei 
by immunodepletion as described above. Initial attempts to 
block chromatin condensation by preincubating the inter- 
phase nuclei with various topo II antibodies (two polyclonals 
and one monoclonal) have been unsuccessful. However, it is 
possible  that  epitopes  recognized  by  the  antibodies  are 
masked in interphase nuclei, or that the antibodies do not in- 
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companies chromatin condensation in vitro 
using mitotic extracts. Nuclei purified from 
MSB-I cells were treated with lysis buffer 
(A and B) or mitotic extract (C and D). (A 
and C) DAPI staining of DNA. (B and D) 
visualization of the nuclear lamina by im- 
munofluorescence  with  a  chicken  lamin 
B2-specific antibody. Bar, 10/zM. 
terfere with the function of the protein. To examine the role 
of endogenous nuclear topo II  in  condensation,  we have 
therefore resorted to the use of a system where nuclei natu- 
rally devoid of topo II are used as substrates for the conden- 
sation reaction. 
In Vitro Condensation of Chromatin from 
Chick Erythroblast Nuclei Varies with the Level 
of  Endogenous Topo H 
Previous work  from many  laboratories has  demonstrated 
that topo II is expressed preferentially in actively proliferat- 
ing cells (5, 16, 33, 36). Specifically, we have shown that dur- 
ing chicken embryogenesis, total cellular topoisomerase II 
levels in  erythroblasts decrease dramatically concomitant 
with the cessation of cell division (16).  As shown in Table 
I, the level of topoisomerase II in MSB-1 cells is 4.9  ×  105 
copies per cell. By quantitative immunoblotting, we have de- 
termined that there are 1.1  x  105 copies of topo II per cell 
in erythroblasts from 3-d chick embryos. This level is rela- 
tively stable until day 6 of embryogenesis, when the level be- 
gins to rapidly decrease.  In erythroblasts from day 7  em- 
bryos, there are 4  x  104 copies per cell, and by day 9 there 
are only 1.6  x  10  4 copies per primitive erythrocyte. In ma- 
ture chick erythrocytes, topo II is undetectable by immuno- 
blotting (i.e., <100 copies per cell) (15). 
We have taken advantage of the erythroid developmental 
lineage to examine the relationship between the level of en- 
dogenous topo II and competence in our chromatin conden- 
sation assay. Nuclei from day 3 erythroblasts readily undergo 
chromatin condensation when incubated with mitotic extract 
(Fig. 8 b). We consistently noted that the degree of conden- 
sation is not as complete as when MSB-1 nuclei are used as 
substrate (Fig. 1 b). This may be the result of  either the lower 
levels of endogenous topo II or other changes in  nuclear 
structure. 
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tract.  Lanes 1-4, 2 #1 of mitotic extract  after immunodepletion 
(supernatant) were diluted with sample buffer to 20 #1; and elee- 
trophoresed on a 10% SDS polyacrylamide gel. The gel was trans- 
ferred to nitrocellulose and probed with antitopo 11 antibody. Lane 
1, untreated mitotic extract. Lane 2, mitotic extract treated for im- 
munodepletion using Pansorben only. Lane 3, mitotic extract treat- 
ed for immunodepletion using preimmune  serum and Pausorben. 
Lane 4, mitotic extract treated for immunodepletion using anti-tope 
H antibodies and Pansorben.  Lanes 6-8, the immunopreeipitated 
material  (pellet) was released  from the Pansorben  by boiling  in 
sample buffer and analyzed by immunoblotting  on the same gel. 
Lanes 6, pellet from immunodepletion with Pansorben only. Lane 
7, pellet from immunodepletion with preimmune serum and Pan- 
sorben. Lane 8, pellet from immunodepletion with anti-topo 1I anti- 
bodies and Pansorben. 
We have used a counting assay to estimate the ability of 
nuclei to form discrete chromosome-like structures when in- 
cubated with this extract. Briefly, we score a nucleus as con- 
densed if at least four distinct regions of condensed chroma- 
tin are visible after incubation with the extract followed by 
DAPI staining.  Nuclei  with  fewer than  four  distinct  con- 
densed  regions  are  scored  as  not  condensed.  Using  this 
method,  we determined  that  56%  of the  3-d erythroblast 
nuclei condense under these conditions (Table I). Longer in- 
cubations do not change the extent of condensation or the 
percentage of nuclei condensed. Using MSB-1 nuclei as sub- 
strate, virtually 100 % of the nuclei condensed in this extract. 
Nuclei  from 5-d  erythroblasts  also  condense  when  in- 
cubated with mitotic extract (Fig.  8 d).  The proportion of 
nuclei condensed using 5-d erythroblasts decreased to 36 % 
(Table I). Using 7-d erythroblasts, only 29% of the nuclei are 
condensed,  and the majority of the nuclei appear to be re- 
duced in volume (Fig. 8 f). Nuclei from 9-d chick primitive 
erythrocytes are unable to condense into discrete structures 
when incubated with mitotic extracts (Fig.  8 h). 
Interestingly,  measurements  of the  area  of  the  DAPI- 
stained chromatin indicate that the volume occupied by the 
chromatin within the 7- and 9-d nuclei decreases upon ex- 
posure to mitotic extract (Table II). Areas of images of the 
Figure 7. Chromatin condensation in vitro using extract lacking oe- 
teetable  topoisomerase II.  Nuclei  purified  from logarithmically 
growing MSB-I cells were incubated with (A) lysis buffer, (B) mi- 
totic extract, and (C) mitotic extract from which all detectable topo 
11 has been removed by immunodepletion. Topo II levels present in 
the extracts used in this experiment are shown in Fig. 6 (lane 1, mi- 
totic extract, lane 4, topo H-depleted mitotic extract). Bar, 10 #M. 
nuclei used in this study were determined using the Hyper- 
vision image processing system, and the corresponding nu- 
clear volumes were determined (see Materials and Methods). 
The total volume occupied by the condensed chromosome- 
like structures  (condensed  structures  and  area in between 
them) in MSB, 3-d, and 5-d nuclei is roughly equivalent to 
the original nuclear volume (Table II). However, the volume 
occupied by the chromatin in the 7- and 9-d nuclei is reduced 
by more than twofold upon treatment with mitotic extract. 
Thus, even though the chromatin within the 7- and 9-d nuclei 
does not resolve into discrete structures, it is compacted into 
a  smaller volume. 
Table L Endogenous Nuclear Topo H Levels Correlate with 
Condensation Ability 
No. of topo II monomers 
Nuclei  (x  105/nucleus)  Condensation 
% 
MSB-  1  4.9  >90 
3-d erythroblast  1.1  56 
5-d erythroblast  0.99  36 
7-d erythroblast  0.40  29 
9-d erythrocyte  0.16  <5 
The number  of topo II monomers  per nucleus was estimated  as described in 
Materials and Methods. The percent  condensation  represents  the percentage  of 
nuclei containing at least four discretely condensed regions. 
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taining variable  levels of endogenous topoisomerase 
H. Purified erythroblast nuclei from various stages of 
chicken development were incubated with lysis buffer 
(,4, (7, E, and G) or mitotic extract (B,/9, F, and H). 
(,4 and B ) 3-d erythroblast nuclei. (C and D) 5-d ery- 
throblast nuclei. (Eand F) 7-d erythroblast nuclei.  (G 
and H) 9-d primitive erythrocyte nuclei. Bar, 10 tLM. 
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Nuclear Volume 
Volume  Volume  Original 
Nuclei  buffer-treated  extract-treated  volume 
/,M  e  % 
MSB-1  785  +  123  t,119  +  211  142 
3-d  497  5- 26  584  +  93  118 
5-d  326  5- 40  227  +  34  70 
7-d  429  5- 7  187  5- 23  44 
9-d  316  5-  33  117  5- 11  37 
Nuclear volumes were calculated as described in Materials and Methods. Each 
volume represents the average of 20 individual nuclei. For condensed nuclei the 
volume  was calculated  based  upon the  area  contained  within  the  complete 
residual nucleus. 
These results demonstrate that the degree of resolution of 
interphase chromatin into discrete condensed regions corre- 
lates with the level of endogenous topoisomerase II, but that 
the  compaction  of the  chromatin  does  not  require  this 
enzyme. 
Discussion 
Although much progress has been made recently in under- 
standing events that control the entry into mitosis, very little 
is known about the immediate events leading to mitotic chro- 
mosome condensation. To further our understanding of the 
details of this process, we have developed a somatic cell ex- 
tract that promotes chromatin condensation of added inter- 
phase nuclei in vitro. 
Previously described in vitro chromosome condensation 
systems developed from Xenopus egg extracts yield chromo- 
somes with excellent morphology (26,  28,  30).  However, 
these extracts contain large stockpiles of chromosomal pro- 
teins (,~1.4  ×  101° monomers of topo II per egg, for exam- 
ple  [27]),  and apparently use these to remodel substrate 
nuclei before chromosome condensation (14, 28).  For this 
reason, Xenopus extracts may not be ideal for experiments 
designed to take advantage of the particular protein content 
of the substrate nuclei. Thus we have developed tissue cul- 
ture  cell  extracts that do  not contain large  stockpiles of 
chromosomal proteins to drive chromosome condensation. 
These extracts also enable us to take advantage of specific 
antibody probes to chromosome scaffold proteins developed 
previously in this laboratory (3, 9,  17,  19, 32). 
Using our somatic extract system, we hope to identify 
specific structural proteins or modifications to such proteins 
directly involved in the condensation process. For the results 
of such an approach to be valid, it is of utmost importance 
that the reaction observed in vitro be an accurate model of 
what occurs in vivo.  Several lines of evidence suggest that 
our in vitro system meets this criterion. 
(a) The in vitro chromatin condensation reaction results in 
the formation of discrete condensed regions of chromatin. 
These regions are frequently linear,  like mitotic chromo- 
somes, and the number of structures observed roughly corre- 
lates with the karyotype of the substrate nuclei (Fig. 2). Al- 
though the structures formed in vitro are similar to the early 
condensation foci observed in the elegant in vivo analysis of 
chromosome condensation in Drosophila melanogaster em- 
bryos (18), it will be necessary in future experiments to fol- 
low the in vitro condensation process in real time to assess 
the extent to which the in vivo and in vitro processes resem- 
ble on another. At present we cannot determine if mitotic 
chromosomes per se are formed during the reaction, or if  the 
structures observed represent some intermediate stage of the 
condensation process. 
(b) Nuclear lamina solubilization, which also occurs dur- 
ing normal mitosis, accompanies chromatin condensation in 
vitro (Fig. 5). An interesting aspect of this reaction is that 
the condensed regions of chromatin often remain associated 
even though the nuclear lamina is ~87%  solubilized. This 
continued association may be mediated by a low level of un- 
solubilized nuclear lamins, residual nuclear membrane, or 
incomplete untangling of intertwined DNA strands during 
the condensation process. 
(c)  The in vitro chromatin condensation reaction is in- 
hibited by several factors that, if  anything, might be expected 
to increase the degree of nonspecific chromatin aggregation, 
such as increased concentrations of divalent cations. Brief 
heat treatment of the extract also abolishes condensation, 
implying that the reaction requires extract proteins in their 
native state. 
(d) Chromatin-condensing activity is greatly enhanced in 
extracts from mitotic cells (Fig. 3). Mitotic extracts contain 
consistently high levels of condensing activity (80--100% of 
nuclei condense). We have observed low and variable lev- 
els of chromatin condensation in extracts prepared from log- 
arithmically growing cells, but the level of condensing ac- 
tivity in these extracts is much lower than that observed with 
mitotic extracts. The reason for the low level of condensing 
activity in interphase extracts is not known, but may be the 
result of the artifactual activation of p34  ~d'2 by phosphatases 
liberated during the freeze-thaw grinding lysis procedure. 
Alternatively, a downstream component of the mitotic cas- 
cade may be irreversibly activated in those cells about to en- 
ter mitosis in the interphase populations. Nevertheless, the 
consistently higher level of  condensing activity in mitotic ex- 
tracts strongly suggests that chromatin condensation in vitro 
is dependent upon specific factors present at mitosis, such 
as MPF. 
Considering the observations presented above,  we sug- 
gest that our mitotic extracts faithfully reproduce several 
aspects of naturally occurring chromatin condensation, and 
provide a unique opportunity to investigate structural altera- 
tions and controls of mitotic chromosome condensation in 
somatic ceils. 
The Role of Topoisomerase H in 
Chromosome Condensation 
The classical enzymatic activity of topoisomerase H is the 
alteration of the topological structure of DNA brought about 
by transiently breaking and rejoining both strands of the 
DNA helix (25,  42).  The need for this activity has been 
clearly demonstrated for the process of chromosome segre- 
gation at anaphase (4, 21, 34, 40), and it is hypothesized that 
the enzyme may be involved in regulating supercoiling dur- 
ing RNA transcription (38, 43). Genetic evidence and an in 
vitro inhibitor study using Xenopus extracts also suggest that 
the enzyme may be involved in chromosome condensation 
(30, 39). Our approach to test this hypothesis has been to in- 
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where the level of topo II varies. 
Since topo II is present in both purified nuclei and mitotic 
extracts, both sources of the protein must be considered. Im- 
munodepletion of topo H from the mitotic extract does not 
affect chromatin condensation when nuclei purified from ac- 
tively growing tissue culture ceils are used as  substrates. 
These nuclei have high levels of endogenous topo II that 
therefore must be capable of fulfilling the need for the en- 
zyme, if such a need exists. 
We have taken advantage of the erythroid lineage in the 
embryonic chick, where topo II levels decrease dramatically 
during development, to examine the dependence of conden- 
sation on the presence of endogenous topo H. The nuclei 
from primary circulating erythroblasts rapidly lose topo II 
as the cells cease proliferation during the developmental pro- 
cess (16).  Using these nuclei as substrates of the in vitro 
chromatin condensation reaction, we have demonstrated that 
the ability of the interphase chromatin to condense into dis- 
crete chromosome-like structures varies with topo II levels 
in the purified nuclei. 
Even though topo II levels correlate with the ability of the 
interphase chromatin to condense into discrete regions, it re- 
mains  possible that the  inability of late-stage erythrocyte 
nuclei  to  undergo  this  process  is  due  to  some  as  yet 
unidentified nuclear protein lost during erythroid develop- 
ment or other overall rearrangements in nuclear structure. 
To distinguish between these possibilities, we have attempted 
to restore the formation of discrete condensed regions by 
adding purified topo II back to the late stage chick erythro- 
cyte nuclei. Although we have used several different sources 
of  topo II including enzyme purified from calf thymus, HeLa 
ceils, T2 phage, and chicken we have been unable to consis- 
tently restore the  formation of. discrete chromosome-like 
structures. 
We have considered two possible explanations for these 
results: other proteins lost during erythropoiesis may be ex- 
clusively required, or required in combination with topo II 
to  restore chromosome formation.  Alternatively,  topo II 
may be all that is required for chromosome formation, but 
the enzyme may not function properly, unless it is incorpo- 
rated into an appropriate nuclear structure (possibly at the 
base of chromatin loop domains). Such a structure may not 
be easily formed simply by adding the enzyme back to the 
purified nuclei in these somatic cell extracts. For example, 
formation of this hypothetical structure might require the 
presence of topo 1I during a specific stage of the cell cycle 
such as DNA replication. 
There Appear to Be Two Aspects of Chromatin 
Condensation In Vitro 
Interestingly, the loss of topo II does not prevent condensa- 
tion of the interphase chromatin into a more compact vol- 
ume. Thus it appears that overall chromosome condensation 
may involve two different processes, compaction of the chro- 
matin and resolution of the individual chromosomes. The 
chromatin compaction process may be mediated by histone 
phosphorylation, which has long been known to correlate 
with the timing of mitosis. 
Our results with 7- and 9-d erythrocyte nuclei suggest that 
topo II is not required for the compaction process but may 
be required for the resolution process. A role for topo II in 
the resolution process makes functional sense considering 
the basic strand breakage-rejoining activity of the enzyme. 
However, the 9-d erythrocyte nuclei used in this assay are ar- 
rested in Go. Therefore, the resolution process required for 
this condensation is not the same as the post-replicative reso- 
lution of sister chromatids that occurs at anaphase (4, 21, 34, 
40). The mechanism of this chromatin resolution potentially 
mediated by topo II is unclear. But given that the addition 
of soluble active enzyme does not restore this process, it is 
interesting to speculate that topo II must be incorporated 
into an appropriate macromolecular structure to function in 
this capacity. 
In the future we hope to use our in vitro chromatin conden- 
sation system to help clarify the chromatin resolution pro- 
cess, by searching for other factors that might be needed to 
restore the formation of discrete condensed regions in late 
stage chick erythrocytes. Furthermore, the identification of 
two  aspects  of chromatin  condensation  (compaction and 
resolution) should allow us to more clearly define roles for 
events,  such  as  histone phosphorylation,  in  chromosome 
condensation. 
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Note Added in Proof. The failure of 9-d erythrocyte nuclei to condense is 
not due to inability of the extracts to solubilize the lamina. When these 
nuclei are incubated in the extract, 74%  of lamin B2 is solubilized (as 
judged by quantitation of immunofluorescence). 
We have recently developed a  reproducible protocol by which highly 
purified topo II is able to restore the condensation phenotyp¢ to 9-d (and 
later) erythrocyte nuclei (Wood, E., M. Muller, and W. Earnshaw, unpub- 
lished results). This offers strong support for the conclusion that topo II is 
required for the in vitro condensation process. 
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